Winsome Chung

Winsome Chung joined Lycia Therapeutics as Vice President, Finance in May 2022. She has over 20 years of finance, accounting and business operations experience in both private and publicly traded companies across multiple industries including early stage to late stage life science companies. Before joining Lycia, she served as Head of Financial Planning and Analysis at ArsenalBio where she led the corporate and strategic planning function. Prior to ArsenalBio, Winsome held multiple roles at NGM Biopharmaceuticals where she served as Controller as well as Executive Director of FP&A. During her tenure there she built out and scaled the accounting and finance functions and supported the company’s initial public offering. Winsome holds a B.S. in Business Administration from the University of California, Berkeley.